Vivakor Announces The Launch Of Its Second Generation VivaThermic Cryovials Designed Specifically For Stem Cell Research

Vivakor, Inc. (OTCBB: VIVK) announced the development of its second generation VivaThermic Cryovials. The VivaThermic 2.0 cryovials were specifically designed to facilitate improved cryopreservation of induced Pluripotent Stem cells (iPS cells) and protein-induced Pluripotent Stem cells (piPS)…

More: continued here

Filed under: Stem Cell Research on February 9th, 2010